[1] KULLAK UBLICK GA,ANDRADE RJ,MERZ M,et al. Drug induced liver injury:Recent advances in diagnosis and risk assessment[J]. Gut,2017,66(6):1154-1164.
|
[2] DALY AK,DONALDSON PT,BHATNAGAR P,et al. HLA-B*5701 henotype is a major determinant of drug-induced liver injury due to flucloxacillint[J]. Nat Genet,2009,41(7):816-819.
|
[3] HUSSANI SH,FARRINGTON EA. Idiosyncratic drug-induce liver injury:An update on the 2007 overview[J]. Expert Opin Drug Saf,2014,13(1):67-81.
|
[4] MONSHI MM,FAULKNER L,JENKINS RE,et al. Human Leukocyte Antigen(HLA)-B(star)57∶01-restricted activation of drug-specific t cells provides the immunological basis for flucloxacillin-induced liver injury[J]. Hepatology,2013,57:727-739.
|
[5] ANA A,FAVIEL G,CATHERINE B,et al. In silico analysis of HLA associations with druginduced liver injury:Use of a HLA-genotyped DNA archive from healthy volunteers[J]. Genome Med,2012,4:51.
|
[6] POSADAS S,PICHLER E. Delayed drug hypersensitivity reactions[J]. Ann Intern Med,2007,39(8):683-693.
|
[7] HAN Y,CHEN J,SHAN J,et al. Value of fumarate hydratase antibody in differential diagnosis of autoimmune hepatitis and drug-induced liver injury[J]. J Clin Hepatol,2019,35(6):1326-1329.(in Chinese)韩莹,陈杰,单晶,等.抗延胡索酸水合酶抗体对自身免疫性肝炎和药物性肝损伤的鉴别诊断价值[J].临床肝胆病杂志,2019,35(6):1326-1329.
|
[8] ZHANG YM,SUN WJ,WEN LZ,et al. Clinical features of patients with drug-induced liver injury in China in the last five years[J]. J Clin Hepatol,2018,34(3):562-566.(in Chinese)张艳梅,孙文静,文良志,等.近5年我国药物性肝损伤患者临床特征分析[J].临床肝胆病杂志,2018,34(3):562-566.
|
[9] Drug-induced Liver Disease Study Group,Chinese Society of Hepatology,Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. J Clin Hepatol,2015,31(11):1752-1769.(in Chinese)中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
|
[10] ANAN G,BENICHOU C. Causality assessment of adverse reactions todrugs IA novel method based o A the conclusions of international consensus meetings:Application to drug induced liver injuries[J]. J Clin Epidemiol,1993,46(11):1323-1330.
|
[11] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.
|
[12] European Association for the Study of the Liver. EASL clinical practice guidelines:Drug-induced liver injury[J]. J Hepatol,2019,70(6):1222-1261.
|
[13] DONG L,BAI J,JIANG X,et al. The gene polymorphisms of IL-8(-251T/A)and IP-10(-1596C/T)are associated with susceptibility and progression of type 2 diabetic retinopathy in northern Chinese population[J]. Eye(Lond),2017,31(4):601-607.
|
[14] RUSSMANN S,JETTER A,KULLAK GA. Pharmacogenetics of drug-induced liver injury[J]. Hepatology,2010,52:2-10.
|
[15] GIOVANNI B,ELISABETTA V,VALENTINA B. High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma[J]. Leuk Lymphoma,2017,58(10):2493-2496.
|
[16] ALI R,SADAF F,SHAGUFTA K,et al. The association of urinary interferon-gamma inducible protein-10(IP10/CXCL10)levels with kidney allograft rejection[J]. Inflamm Res,2017,66(5):425-432.
|
[17] ANAJALI J,ERIN B,TUGBA MG,et al. TLR9 polymorphism correlates with immune activation,CD4 decline and plasma IP10 levels in HIV patients[J]. BMC Infect Dis,2019,19(1):56.
|
[18] LIN C,YAN HY,YANG HY,et al. Combination of DESI2 and IP10 gene therapy significantly improves therapeutic efficacy against murine carcinoma[J]. Oncotarget,2017,8(34):56281-56295.
|
[19] WENNERBERG E,KREMER V,CHILDS R,et al. CXCL10 induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo[J]. Cancer Immunol Immunother,2015,64(2):225-235.
|
[20] WANG J,VODOVOTZ Y,FAN L,et al. Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages[J]. FASEB J,2015,29(1):250-262.
|
[21] XIE ZY,CHEN EM,OUYANG XX,et al. Metabolomics and cytokine analysis for identification of severe drug-induced liver injurys[J]. J Proteome Res,2019,18(6):2514-252
|
[22] PASTOR L,CASELLAS A,RUPEREZ M,et al. Interferongamma-inducible protein 10(IP-10)as ascreening tool to optimize human immunodeficiency virus RNA monitoring inresource-limited settings[J]. Clin Infect Dis,2017,65(10):1670-1765.
|
[23] CHANDRIKA B,PARTHA PM,BHASWATI P. CXCL10 is overexpressed in active tuberculosis patients compared to M. tuberculosis-exposed household contacts[J]. Tuberculosis(Edinb),2018,109:8-16.
|